Living

Sun Pharma to acquire Innovcare Lifesciences for $28.7 million

By Reuters Reuters
A man speaks on his phone next to the logo of Sun Pharmaceutical Industries Ltd., in Mumbai, India, October 31, 2025. REUTERS/Francis Mascarenhas
A man speaks on his phone next to the logo of Sun Pharmaceutical Industries Ltd., in Mumbai, India, October 31, 2025. REUTERS/Francis Mascarenhas Francis Mascarenhas Reuters

Sun Pharmaceutical Industries on Saturday said it will acquire 100% of Innovcare Lifesciences in a deal valued at about 2.71 billion rupees ($28.73 million).

($1 = 94.3200 Indian rupees)

(Reporting by Devika Nair in Bengaluru; Editing by Alexandra Hudson)

Copyright Reuters or USA Today Network via Reuters Connect

This story was originally published June 20, 2026 at 5:17 AM.

Get unlimited digital access
#ReadLocal

Try 1 month for $1

CLAIM OFFER